ID: ALA5184919

Max Phase: Preclinical

Molecular Formula: C29H43ClF3N5O8S2

Molecular Weight: 746.27

Associated Items:

Representations

Canonical SMILES:  CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CC[C@H](NS(=O)(=O)c1ccc(Cl)c(C(F)(F)F)c1)C(=O)O)C(N)=O

Standard InChI:  InChI=1S/C29H43ClF3N5O8S2/c1-15(2)12-22(26(41)37-23(13-16(3)4)27(42)36-20(25(34)40)10-11-47-5)35-24(39)9-8-21(28(43)44)38-48(45,46)17-6-7-19(30)18(14-17)29(31,32)33/h6-7,14-16,20-23,38H,8-13H2,1-5H3,(H2,34,40)(H,35,39)(H,36,42)(H,37,41)(H,43,44)/t20-,21-,22-,23-/m0/s1

Standard InChI Key:  SGWHMGPSQUGNOO-MLCQCVOFSA-N

Associated Targets(Human)

Matrix metalloproteinase 7 1073 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 746.27Molecular Weight (Monoisotopic): 745.2194AlogP: 2.66#Rotatable Bonds: 20
Polar Surface Area: 213.86Molecular Species: ACIDHBA: 8HBD: 6
#RO5 Violations: 2HBA (Lipinski): 13HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.33CX Basic pKa: CX LogP: 2.72CX LogD: -0.70
Aromatic Rings: 1Heavy Atoms: 48QED Weighted: 0.12Np Likeness Score: -0.83

References

1. Tabuse H, Abe-Sato K, Kanazawa H, Yashiro M, Tamura Y, Kamitani M, Hitaka K, Gunji E, Mitani A, Kojima N, Oka Y..  (2022)  Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1' Subsite Binder with Short Peptides.,  65  (19.0): [PMID:36137271] [10.1021/acs.jmedchem.2c01088]

Source